NFE2L2 and chronic obstructive pulmonary disease: The data also suggest that stimulation of antioxidative response through activation of NRF2 may be a pharmacologically important part of the actions of AuNPs in this model, providing novel perspectives for treating steroid-insensitive asthma and COPD at the interface of biological systems and nanomedicine.